Feblead 40 Tablet contains Febuxostat 40mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat works by selectively inhibiting xanthine oxidase, an enzyme responsible for converting purines into uric acid, thereby reducing serum uric acid levels. This reduction helps prevent gout attacks, which are caused by the deposition of urate crystals in joints and tissues. Feblead 40 is typically prescribed for patients who have not responded well to other urate-lowering therapies or who are intolerant to allopurinol. The tablet is taken orally, usually once daily, with or without food, as directed by a healthcare professional. Common side effects may include nausea, joint pain, rash, and liver enzyme abnormalities, so regular monitoring of liver function tests is recommended during treatment. Febuxostat should be used cautiously in patients with cardiovascular disease or impaired liver function. It is important to maintain adequate hydration while on this medication to prevent kidney stones. Feblead 40 is not intended for use in acute gout attacks but rather for long-term management to reduce uric acid levels and prevent future flare-ups. Always consult a healthcare provider before starting or stopping this medication.

Dosage & How to Use